Ptorlimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ptorlimab, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies [Phase 2]